National Waste Management Holdings, Inc. (NWMH) Plans Further Growth with Targeted Acquisitions
In its latest quarterly report (10-Q), National Waste Management Holdings (OTC: NWMH), a solid waste management company headquartered in central…
Blog
Citius Pharmaceuticals, Inc. (CTXR) is “One to Watch”
Citius Pharmaceuticals, Inc. (OTCQB: CTXR), a specialty biopharmaceutical company that develops and commercializes therapeutics products, has been a topic of…
Agora Holdings, Inc. (AGHI) – Framing the Narrative for Social Brands
The human imagination is capable of incredibly brilliant creations, including the technological innovations that Agora Holdings, Inc. (OTC: AGHI) is…
Zogenix, Inc. (ZGNX) Develops Orphan Drug for Dravet Syndrome Epilepsy
Zogenix, Inc (NASDAQ: ZGNX) is a clinical stage pharmaceutical company committed to the development and commercialization of therapies for central…
Matinas BioPharma Holdings, Inc. (MTNB) is “One to Watch”
Matinas BioPharma Holdings, Inc. (OTCQB: MTNB), is a biopharmaceutical company still in its clinical stages, focused on identifying and developing…
Monaker Group, Inc. (MKGI) and Recruiter.com Announce Launch of Custom Travel Rewards Club
Before the opening bell, Monaker Group, Inc. (OTCQB: MKGI) announced the launch of a new travel service and loyalty program…
Dynagas LNG Partners LP (DLNG) is “One to Watch”
According to a past article on MarketWatch (http://dtn.fm/ruK1O), after the Fukushima nuclear disaster there was an increase in liquefied natural…
Monaker Group, Inc. (MKGI) Building Innovative Travel Products for Work and Play
For six decades, Monaker Group (OTCQB: MKGI) has catered to leisure travelers seeking to book “vacations of a lifetime” or…
eXp World Holdings, Inc. (EXPI) Welcomes Marsee Wilhems Team to eXp Realty
Earlier today, eXp World Holdings, Inc. (OTCQB: EXPI) announced that the Tucson-based Marsee Wilhems Team, one of the premier real…
Recro Pharma, Inc. (REPH) Says No to Opioids for Post-Operative Pain Control with IV Meloxicam
An announcement earlier this week from revenue-generating specialty pharmaceutical company Recro Pharma, Inc. (NASDAQ: REPH) is good news for those…